ArticleMicrobiology spectrum2024

Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds.

Sabine Schuster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.